Dupan 2 Pancreas Cancer Associated Antigen, Human

Overview

Dupan 2 is a tumor-associated antigen used as a serum biomarker in the detection and monitoring of pancreatic cancer and other gastrointestinal malignancies. Research published in Pancreas has examined the clinical utility of various tumor markers, including Dupan 2, in the context of pancreatic disease diagnosis and management. Studies have compared the predictive value of different biomarkers at initial patient presentation, evaluating how Dupan 2 and related antigens perform alongside more commonly used markers such as CA 19-9, carcinoembryonic antigen, and bilirubin levels in identifying pancreatic malignancy. The journal has also documented cases involving challenging pancreatic conditions where biomarker interpretation plays a role in differential diagnosis, including distinguishing malignant processes from inflammatory conditions such as groove pancreatitis. Understanding the performance characteristics and limitations of pancreatic cancer-associated antigens matters because accurate early detection and appropriate monitoring can influence treatment decisions and patient outcomes. The comparative assessment of multiple biomarkers helps clinicians determine which tests provide the most reliable diagnostic information in different clinical settings, from tertiary referral centers to community hospitals where patient populations and resource availability may vary.

Research published in this journal

2 peer-reviewed articles, ranked by relevance. Each links to its DOI.

This page summarises published research for orientation; it is not medical or professional advice.

Related topics